Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 3;10:1204071. doi: 10.3389/fcvm.2023.1204071

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Buckler, Doros, Kinninger, Lakshmanan, Le, Libby, May, Muhlestein, Nelson, Nicolaou, Roy, Shaikh, Shekar, Tayek, Zheng, Bhatt and Budoff.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

An example of stabilization/regression of patient on IPE. Overview of quantitation at two encounters of a patient on drug: 53-year-old White female, baseline serum EPA 15.5, increasing to 125.2 at the 9-month follow-up. The 3D view of RCA, LAD, and LCX, with corner annotations for left coronary. The baseline values for LRNC volume, minimum cap thickness, maximum wall thickness, and IPH volume are 329.5 mm³, 204 μm, 5.1 mm, and 122.7 mm^3, respectively. At follow-up, LRNC decreased to 252.5 mm³, IPH to 74.6 mm³, cap thickness increased to 267 μm, and wall thickness decreased to 4.3 mm. The presentation of residual LRNC indicates splitting into smaller lipid pools from larger contiguous cores at baseline. The 2D cross-section located at cursors in 3D representation shown as insets. Serum EPA values for baseline and follow-up are also shown.